Epilepsy Market Scope And Analysis

  • Report Code : TIPRE00016405
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 230
Buy Now

Epilepsy Market Scope and Analysis by 2031

Buy Now

Epilepsy Market Report Epilepsy Market Size and Share Epilepsy Market Scope and Analysis

Epilepsy Market Report Scope

Report Attribute Details
Market size in 2022 US$ 7.7 Billion
Market Size by 2030 US$ 10.7 Billion
Global CAGR (2022 - 2030) 4.1%
Historical Data 2020-2021
Forecast period 2022-2030
Segments Covered By Type
  • Progressive Myoclonic Epilepsy
  • Reflex Epilepsy
  • Generalized Epilepsy
By Route of Administration
  • Oral
  • Parenteral
By Treatment Type
  • First-Generation Drugs
  • Second-Generation Drugs
  • Third-Generation Drugs
By Age Group
  • Adults
  • Children
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Idexx Laboratories Inc
  • PBD Biotech Ltd
  • Thermo Fisher Scientific Inc
  • Innovative Diagnostics SAS
  • Neogen Corp
  • Enfer Labs
  • bioMerieux SA
  • Ring Biotechnology Co Ltd
  • Bionote Inc
  • Shenzhen Bioeasy Biotechnology Co Ltd

    • Epilepsy Market News and Recent Developments

    The epilepsy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:

    • In May 2023, the biotechnology company Neuro3 Therapeutics (Neuro3), which focuses on finding and creating novel medications to treat illnesses of the central nervous system has signed an exclusive global license and option deal with Lundbeck. The agreement focuses on KCNQ2 ion channel activators, which have been clinically verified as targets for epilepsy treatment. According to clinical research, KCNQ2 channel activation may offer therapeutic alternatives for treating various neurological conditions, such as uncommon forms of epilepsy. (Source: Neuro3 Therapeutics company website)

    Epilepsy Market Report Coverage and Deliverables

    The “Epilepsy Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering the following areas:

    • Epilepsy Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Epilepsy Market trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Epilepsy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Epilepsy Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles